Evercore Wealth Management Has Increased Medtronic Plc (MDT) Stake; Arbiter Partners Capital Management Lifted Sportsman’s Warehouse Holdin (SPWH) Stake

February 19, 2018 - By Winifred Garcia

Arbiter Partners Capital Management Llc increased Sportsman’s Warehouse Holdin (SPWH) stake by 17.21% reported in 2017Q3 SEC filing. Arbiter Partners Capital Management Llc acquired 380,000 shares as Sportsman’s Warehouse Holdin (SPWH)’s stock rose 8.37%. The Arbiter Partners Capital Management Llc holds 2.59 million shares with $11.67M value, up from 2.21M last quarter. Sportsman’s Warehouse Holdin now has $223.54 million valuation. The stock increased 4.79% or $0.24 during the last trading session, reaching $5.25. About 422,652 shares traded. Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) has declined 41.90% since February 19, 2017 and is downtrending. It has underperformed by 58.60% the S&P500.




Evercore Wealth Management Llc increased Medtronic Plc (MDT) stake by 87.18% reported in 2017Q3 SEC filing. Evercore Wealth Management Llc acquired 15,812 shares as Medtronic Plc (MDT)’s stock rose 5.51%. The Evercore Wealth Management Llc holds 33,949 shares with $2.64 million value, up from 18,137 last quarter. Medtronic Plc now has $112.76 billion valuation. The stock increased 0.45% or $0.37 during the last trading session, reaching $83.31. About 6.86M shares traded or 28.05% up from the average. Medtronic plc (NYSE:MDT) has risen 4.04% since February 19, 2017 and is uptrending. It has underperformed by 12.66% the S&P500.

Evercore Wealth Management Llc decreased Core Laboratories N V (NYSE:CLB) stake by 8,297 shares to 232,837 valued at $22.98M in 2017Q3. It also reduced Wisdomtree Tr (DLN) stake by 8,082 shares and now owns 424,849 shares. Schlumberger Ltd (NYSE:SLB) was reduced too.

Investors sentiment increased to 1.12 in Q3 2017. Its up 0.22, from 0.9 in 2017Q2. It improved, as 73 investors sold MDT shares while 392 reduced holdings. 109 funds opened positions while 414 raised stakes. 1.07 billion shares or 1.07% more from 1.06 billion shares in 2017Q2 were reported. 84,698 are owned by Parthenon Llc. Marshwinds Advisory owns 0.6% invested in Medtronic plc (NYSE:MDT) for 16,671 shares. Park Corporation Oh reported 70,822 shares. Huntington Natl Bank invested in 0.16% or 118,521 shares. Oregon Pub Employees Retirement Fund invested 0.18% in Medtronic plc (NYSE:MDT). 19,476 are owned by X Management Co Ltd Limited Liability Company. Kingfisher Capital Ltd reported 10,810 shares stake. Roberts Glore Inc Il, a Illinois-based fund reported 7,373 shares. Alpine Woods Cap Investors Ltd Com has invested 0.62% in Medtronic plc (NYSE:MDT). Creative Planning owns 97,246 shares. Walleye Trading Ltd, Minnesota-based fund reported 27,642 shares. Arizona State Retirement System stated it has 0.35% in Medtronic plc (NYSE:MDT). Blue Chip Prns holds 1,522 shares. Morgan Stanley holds 9.26 million shares or 0.22% of its portfolio. Sunbelt Securities invested in 0.49% or 5,962 shares.

Among 28 analysts covering Medtronic (NYSE:MDT), 18 have Buy rating, 0 Sell and 10 Hold. Therefore 64% are positive. Medtronic had 79 analyst reports since August 10, 2015 according to SRatingsIntel. SunTrust maintained Medtronic plc (NYSE:MDT) on Friday, November 17 with “Buy” rating. Needham maintained the shares of MDT in report on Tuesday, June 7 with “Buy” rating. On Tuesday, September 22 the stock rating was initiated by UBS with “Buy”. BMO Capital Markets maintained Medtronic plc (NYSE:MDT) on Tuesday, August 22 with “Buy” rating. Needham maintained the stock with “Buy” rating in Monday, October 9 report. The company was initiated on Tuesday, August 23 by Citigroup. As per Wednesday, April 19, the company rating was maintained by RBC Capital Markets. The company was upgraded on Tuesday, January 2 by Bank of America. The firm earned “Buy” rating on Tuesday, July 18 by Needham. The stock of Medtronic plc (NYSE:MDT) earned “Buy” rating by Needham on Wednesday, February 22.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: